Riskpilot← Back to searchSign inGet full accessIdogen AB
ABBankruptOrg 5567568521Other research and experimental development on natural sciences and engineering · NACE 7219Est. 20080 employees
Revenue 2022
SEK 0
EBITDA margin
—
-27% vs 2021
Equity ratio
40.2%
Financial strength
Net profit 2022
SEK -47,8M
-23% vs 2021
| Revenue | SEK 0 | — |
| EBITDA | SEK -47,6M | -27% |
| Net profit | SEK -47,8M | -23% |
| Total assets | SEK 9M | -61% |
| Equity | SEK 3,6M | -67% |
| Employees | 0 | — |
Legal name
Idogen AB
Org number
5567568521
Legal form
Aktiebolag
NACE code
7219 · Other research and experimental development on natural sciences and engineering
Founded
24 april 2008
Share capital
SEK 5 102 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder Registrerad kvalificerad revisor saknas.
Company purpose
Föremålet för bolagets verksamhet är att verka inom olika sjukdomsområden innefattande men inte begränsande till autoimmuna sjukdomar, blödarsjuka och transplantion och bedriva forskning och utveckling för att identifiera framtida läkemedel, patentera och kommersialisera nya läkemedel från forskning såväl som repositionering av idag befintliga läkemedel samt därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — | — | — | — |
| EBITDA | −9 661 | −12 583 | −21 224 | −26 870 | −26 931 | −24 828 | −37 547 | −47 585 |
| Depreciation & amort. | −0 | −0 | −75 | −991 | −5 895 | −1 325 | −1 418 | −387 |
| EBIT | −9 661 | −12 583 | −21 299 | −27 861 | −32 826 | −26 153 | −38 965 | −47 972 |
| Net financials | 3 | −16 | −23 | 227 | 133 | −1 346 | 110 | 221 |
| Profit before tax | −9 658 | −12 599 | −21 322 | −27 634 | −32 694 | −26 822 | −38 855 | −47 750 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −9 658 | −12 599 | −21 322 | −27 634 | −32 694 | −26 822 | −38 855 | −47 750 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|---|
| Total assets | 13 279 | 20 668 | 44 187 | 71 674 | 31 189 | 50 843 | 23 069 | 8 996 |
| Equity | 12 168 | 18 596 | 39 888 | 51 023 | 18 329 | 40 621 | 10 986 | 3 612 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 111 | 2 072 | 4 299 | 20 651 | 12 860 | 10 222 | 12 083 | 5 384 |
| Total debt | 1 111 | 2 072 | 4 299 | 20 651 | 12 860 | 10 222 | 12 083 | 5 384 |
EBITDA margin
-4758500000.0%
This company
15.8%
Market median
-30117088708% vs market
20152022
Equity ratio
40.2%
This company
38.2%
Market median
+5% vs market
20152022
Return on equity
-1322.0%
This company
18.4%
Market median
-7285% vs market
20152022
Net profit margin
-4775000000.0%
This company
8.1%
Market median
-58950617384% vs market
20152022
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20152022
Debt / equity
1.49×
This company
0.62×
Market median
-140% vs market
20152022
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MS Chief Auditor | Chief Auditor | 2020 | — | — |
CE Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
AE Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2020 | — | — | |
| Chairman | 2022 | — | — | |
| Chairman | 2020 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Idogen AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Maria Sofia Ekelund | Chief Auditor | 0 companies |
| Christina Elisabeth Herder | Chief Executive Officer | 0 companies |
| Anders Eric Karlsson | Chief Executive Officer | 0 companies |
| Karin Helene Hoogendoorn | Board of Directors | 0 companies |
| Joakim Andreas Söderström | Chairman | 0 companies |
| Eva Agneta Edberg | Chairman | 0 companies |
| Johan Niklas Wallett | Board of Directors | 0 companies |
| Jan Anders Holgersson | Board of Directors | 0 companies |
| Per Olov Lennart Svensson | Board of Directors | 0 companies |
| Sharon Jayne Longhurst | Board of Directors | 0 companies |